MECHANISM OF ADVERSE NURSING

DRUG NAME INDICATION CONTRAINDICATION SIDE EFFECTS

ACTION EFFECTS RESPONSIBILITIES

LIDOCAINE Similar to those of  For the treatment History of hypersensitivity CNS: Headache, Assessment & Drug
procainamide and of perfusing to amide-type local dizziness, fatigue. Effects
Brand Name: quinidine, but has ventricular anesthetics; application or
little effect on arrhythmias injection of lidocaine  GI: Diarrhea,  Lab tests:
Anestacon, Dilocaine, myocardial anesthetic in presence of abdominal pain, Monitor
including
L-Caine, Lidoderm, contractility, AV and severe trauma or sepsis, nausea, mild transient urinalysis for
ventricular
Lida-Mantle, Lidoject- intraventricular blood dyscrasias, increases in liver hematuria and
fibrillation (VF)
1, LidoPen,Auto conduction, cardiac supraventricular function tests.  proteinuria.
and ventricular
Injector, Nervocaine, output, and systolic arrhythmias, Stokes- Periodic liver
tachycardia (VT)
Octocaine, Xylocaine, arterial pressure in Adams syndrome, Urogenital: Hematuria, function tests
that may result
Xylocard equivalent doses. untreated sinus proteinuria.  with prolonged
during acute
Exerts antiarrhythmic myocardial bradycardia, severe use.
Available Form: action (Class IB) by degrees of sinoatrial, Skin: Rash.
infarction or
Antidysrhythmic suppressing atrioventricular, and Patient & Family
cardiac
300 mg/3 mL auto- automaticity in His- intraventricular heart Education
manipulation
injector; 0.2%, 0.4%, Purkinje system and block. Safe use during
(e.g., cardiac
0.8%, 1%, 2%, 4%, by elevating pregnancy (category B),  Report any
surgery).
10%, 20% injections electrical stimulation lactation, or in children is changes in
 For topical
threshold of ventricle anesthesia of skin not established. urinary
Local Anesthetic during diastole. elimination such
and mucous
0.5%, 1%, 1.5%, 2%, Action as local as pain or
membranes or
4% anesthetic is more discomfort
stomatitis.
prompt, more  For prevention of associated with
Topical intense, and longer urination, or
2%, 2.5%, 4%, 5% dental pain† and
lasting than that of for topical blood in urine.
solution; 2.5%, 5% procaine.
ointment; 0.5%, 4% anesthesia of
 Report severe
cream; 0.5%, 2.5% mucous
membranes. diarrhea; drug
gel; 0.5%, 10% spray; may need to be
2% jelly; 0.5% patch  For nonurgent
discontinued.
painful
Dosages: procedures
 Do not breast
including IV
feed while taking
Anesthetic Uses cannulation,
this drug.
Adult: Infiltration 0.5– venipuncture,
1% solution lumbar puncture,
 Nerve Block 1–2% or arterial
solution  puncture.
 For the treatment
Epidural 1–2% solution  of stage 1 thru 4
Caudal 1–1.5% solution  pressure ulcers,
Spinal 5% with glucose venous stasis
Saddle Block 1.5% with ulcers, ulcerations
dextrose of mixed vascular
Topical 2.5–5% jelly, etiologies,
ointment, cream, or diabetic skin
ulcers, first and
solution
second degree
burns, and post
surgical incisions,
cuts, and
abrasions.
 For the treatment
of pain associated
with postherpetic
neuralgia.
 For local
anesthesia
including
peripheral nerve
block anesthesia.
 For epidural
anesthesia.
 For caudal
anesthesia.
 For obstetric
anesthesia.
 For caudal
anesthesia.
 For obstetric
anesthesia.